do-me/EUR-LEX huggingface dataset:
Case C-236/22 P: Appeal brought on 4 April 2022 by Beata Sołowicz against the order of the General Court (Third Chamber) delivered on 28 January 2022 in Case T-725/21, Sołowicz v Commission
Date: 2022-04-04
Institutions: Court of Justice
Subjects: admissibility, economic policy, legal expenses, monetary policy








C_2023045EN.01000301.xml










6.2.2023   


EN


Official Journal of the European Union


C 45/3






Appeal brought on 4 April 2022 by Beata Sołowicz against the order of the General Court (Third Chamber) delivered on 28 January 2022 in Case T-725/21, Sołowicz v Commission
(Case C-236/22 P)
(2023/C 45/03)
Language of the case: Polish

Parties


Appellant: Beata Sołowicz (represented by: M. Korpalski, radca prawny)

Other party to the proceedings: European Commission
By order of 23 November 2022, the Court of Justice (Seventh Chamber) dismissed the appeal as manifestly inadmissible and ordered Ms Beata Sołowicz to bear her own costs.
Case T-175/22: Action brought on 4 April 2022 — Novartis v EUIPO — AstraZeneca (BREZTRI)
Date: 2022-04-04
Institutions: General Court
Subjects: EU trade mark, pharmaceutical product, registered trade mark, trade-mark law








C_2022207EN.01005301.xml










23.5.2022   


EN


Official Journal of the European Union


C 207/53






Action brought on 4 April 2022 — Novartis v EUIPO — AstraZeneca (BREZTRI)
(Case T-175/22)
(2022/C 207/70)
Language in which the application was lodged: English

Parties


Applicant: Novartis AG (Basel, Switzerland) (represented by: A. Nordemann-Schiffel, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: AstraZeneca AB (Södertälje, Sweden)

Details of the proceedings before EUIPO


Proprietor of the trade mark at issue: Other party to the proceedings before the Board of Appeal

Trade mark at issue: European Union word mark BREZTRI — European Union trade mark No 17 816 687

Procedure before EUIPO: Cancellation proceedings

Contested decision: Decision of the Second Board of Appeal of EUIPO of 21 January 2022 in Case R 737/2021-2

Form of order sought

The applicant claims that the Court should:






—


annul the contested decision;










—


order EUIPO to pay the costs.





Pleas in law







—


Infringement of Article 27(3)(b) of Commission Delegated Regulation (EU) 2017/1430;










—


Infringement of Article 60(1)(a) in conjunction with Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.
Non-opposition to a notified concentration (Case M.10531 – SANTANDER / MAPFRE / JV) (Text with EEA relevance) 2022/C 157/02
Date: 2022-04-04
Institutions: Directorate-General for Competition, European Commission
Subjects: Spain, banking, economic concentration, insurance, investment company, merger control, parent company, provision of services, real estate credit








C_2022157EN.01001001.xml










11.4.2022   


EN


Official Journal of the European Union


C 157/10






Non-opposition to a notified concentration
(Case M.10531 – SANTANDER / MAPFRE / JV)
(Text with EEA relevance)
(2022/C 157/02)
On 4 April 2022, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:






—


in the merger section of the ‘Competition policy’ website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,










—


in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32022M10531. EUR-Lex is the online point of access to European Union law.






(1)  OJ L 24, 29.1.2004, p. 1.
Case C-233/22 P: Appeal brought on 4 April 2022 by Meta Cluster GmbH against the judgment of the General Court (Ninth Chamber) delivered on 26 January 2022 in Case T-233/21, Meta Cluster GmbH v European Union Intellectual Property Office
Date: 2022-04-04
Institutions: Court of Justice
Subjects: EU trade mark, dietary product, health service, nutritional needs, optical medium, pharmaceutical product, registered trade mark, trade-mark law, veterinary medicinal product, veterinary medicine








C_2022340EN.01001402.xml










5.9.2022   


EN


Official Journal of the European Union


C 340/14






Appeal brought on 4 April 2022 by Meta Cluster GmbH against the judgment of the General Court (Ninth Chamber) delivered on 26 January 2022 in Case T-233/21, Meta Cluster GmbH v European Union Intellectual Property Office
(Case C-233/22 P)
(2022/C 340/17)
Language of the case: German

Parties


Appellant: Meta Cluster GmbH (represented by: H. Baumann, Rechtsanwalt)

Other party to the proceedings: European Union Intellectual Property Office
By order of 15 July 2022, the Court of Justice of the European Union (Chamber determining whether appeals may proceed) decided that the appeal should not be allowed to proceed and ordered the appellant to bear its own costs.